AMPAC Fine Chemicals and Codexis Enter Into a Manufacturing Partnership

01-Apr-2010 - AMPAC Fine Chemicals LLC (AFC), a subsidiary of American Pacific Corporation announced that it has entered into a manufacturing partnership with Codexis, Inc. Under a new agreement, AFC will partner with Codexis to use Codexis' proprietary biocatalysis technology in combination with AFC's ...

The Dishman Group announces strategic alliance with Codexis

19-Feb-2010 - The Dishman Group announced the formation of a strategic alliance with Codexis, Inc. a California based biotechnology company. This strategic partnership covers the use of Codexis’ proprietary enzymatic biocatalysis technology for the manufacture of building blocks, intermediates and APIs for ...

Dual enzyme biocatalyst

19-Mar-2009 - A range of enantiomerically pure chiral amines have been prepared by a collaboration of scientists in the UK and the US. Nicholas Turner and Matthew Truppo from the University of Manchester and a co-worker from Codexis Incorporated, California, have synthesised a range of enantiomerically pure ...

Codexis Opens Singapore Laboratory

26-Oct-2007 - Codexis, Inc. announced the opening of Codexis Laboratories Singapore Pte. Ltd. (CLS). CLS is the company's first research facility in Asia, and is an expansion of the company's research and development operations in the U.S. and Europe. CLS will support the company's pharmaceuticals business in ...

Codexis Appoints Singapore Laboratories Managing Director

23-Aug-2007 - Codexis, Inc.announced the appointment of Thomas Daussmann, Ph.D., to the new position of Vice President and Managing Director of Codexis Laboratories Singapore Pte. Ltd. CLS is the company's first facility in Asia. Dr. Daussmann will report to Alan Shaw, Ph.D., President and CEO. Since 1999, ...

Codexis Achieves Development Milestone in Research Agreement with Schering-Plough

13-Sep-2006 - Codexis, Inc. announced it has achieved an important development milestone under a research agreement with Schering-Plough Corporation. The objective of the collaboration with Schering-Plough is to rapidly generate a novel biocatalytic process to produce a key intermediate for an undisclosed ...

Codexis to Establish New R&D Facility in Singapore to Support Expanding Generics Business

28-Aug-2006 - Codexis announced that it will establish a research and development center in Singapore, scheduled to open in the third quarter of 2007. The R&D center will focus on new product development for the company's API and generics business. When fully staffed, the center is expected to house up to 80 ...

Codexis Enters Into Research Collaboration With Schering-Plough

23-Mar-2006 - Codexis, Inc. announced that it has signed a research agreement with Schering-Plough Corporation to develop a novel synthetic process for use by Schering-Plough. The collaboration will focus on improving biocatalyst productivity using Codexis' proprietary MolecularBreeding(TM) pharmaceutical ...

Codexis and Bristol-Myers Squibb extend the term of research agreement

Codexis Achieves Milestone

06-Feb-2006 - Codexis, Inc. announced it has extended the term of an existing research agreement with Bristol-Myers Squibb Company. Codexis also announced that it will receive an undisclosed milestone payment for having successfully achieved the program's research milestone. The research agreement was ...

Codexis amd Arch Pharmalabs achieve development milestone

09-Jan-2006 - Codexis, Inc. announced it has achieved an important development milestone under a research and manufacturing agreement with Arch Pharmalabs, Ltd. Arch has successfully integrated Codexis' ThoroughBred(TM) biological catalysts and proprietary biocatalytic system into commercial production of a ...